{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:49:19Z","timestamp":1792792159374,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010790","name":"Erasmus+","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010790","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stipendiafonds"},{"name":"Jo Kolk Studiefonds"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jcrc.2017.04.039","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T16:46:59Z","timestamp":1493225219000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients"],"prefix":"10.1016","volume":"41","author":[{"given":"Elise M.A.","family":"Slob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9650-3718","authenticated-orcid":false,"given":"Rob","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2017.04.039_bb0005","series-title":"Cardiovascular disease statistics 2014","author":"Townsend","year":"2014"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0010","series-title":"National heart failure audit London","author":"Cleland","year":"2013"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0015","series-title":"Acute heart failure: diagnosing and managing acute heart failure in adults","author":"NICE","year":"2014"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0020","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0140-6736(07)61317-8","article-title":"Catecholamine treatment for shock\u2014equally good or bad?","volume":"370","author":"Singer","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure","volume":"153","author":"Elkayam","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/cc10302","article-title":"The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery","volume":"15","author":"Shahin","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0035","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/ALN.0b013e318173026f","article-title":"Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses","volume":"108","author":"Fellahi","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0040","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1476-5381.2011.01588.x","article-title":"Use of inotropes and vasopressor agents in critically ill patients","volume":"165","author":"Bangash","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0050","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0055","first-page":"2227","article-title":"Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiol\u00f3gicos Latinoam\u00e9rica) Collaborative Group","volume":"98","author":"D\u00edaz","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0060","series-title":"Adjuctive use of glucose-insulin-potassium (GIK) versus control in low cardiac output patients: a case controlled comparison [abstract]","first-page":"P146","author":"Shulman","year":"2011"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0065","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-007-0768-y","article-title":"Relative safety of hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study","volume":"33","author":"Greene","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"20","author":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0080","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0085","author":"Governance Arrangements for Research Ethics Committees (GAfREC)"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(04)17412-6","article-title":"The metabolic vicious cycle in heart failure","volume":"364","author":"Opie","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/FJC.0000000000000054","article-title":"Heart failure and loss of metabolic control","volume":"63","author":"Wang","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0105","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.jacc.2009.07.024","article-title":"The adrenergic-fatty acid load in heart failure","volume":"54","author":"Opie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0110","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1\u03b1 and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SHK.0b013e31815abbc6","article-title":"Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability","volume":"29","author":"Nogueira","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0125","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1073\/pnas.1332551100","article-title":"Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts","volume":"100","author":"Stump","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(94)90939-3","article-title":"Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias","volume":"343","author":"Oliver","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0135","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117433","article-title":"Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release","volume":"94","author":"Steinberg","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0140","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.CIR.96.4.1152","article-title":"Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials","volume":"96","author":"Fath-Ordoubadi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejcts.2006.01.023","article-title":"Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials","volume":"29","author":"Schipke","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/bja\/aes324","article-title":"Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery","volume":"110","author":"Shim","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ALN.0000000000000723","article-title":"Hyperinsulinemic normoglycemia does not meaningfully improve myocardial performance during cardiac surgery: a randomized trial","volume":"123","author":"Duncan","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0165","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0091270009334375","article-title":"Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis","volume":"49","author":"Puskarich","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00003246-198507000-00012","article-title":"Use of glucose-insulin-potassium (GIK) in human septic shock","volume":"13","author":"Bronsveld","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0175","first-page":"85","article-title":"Effects of intermittent and long-term glucose-insulin-potassium infusion in patients with systolic heart failure","volume":"13","author":"Kalay","year":"2008","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jcrc.2017.04.039_bb0180","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2215\/CJN.00750111","article-title":"Comparison of insulin action on glucose versus potassium uptake in humans","volume":"6","author":"Nguyen","year":"2011","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944116303483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944116303483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T23:28:40Z","timestamp":1658964520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944116303483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":36,"alternative-id":["S0883944116303483"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.039","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}